AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Russell Schuster has been appointed Chief Commercial Officer, effective December 2nd, 2024.

In his new role, Mr. Schuster will oversee commercial strategy and revenue generation for the Company. He is a seasoned executive with more than 25 years of experience and a proven track record of growing large businesses. Most recently, Mr. Schuster served as President of Cardinal Health Canada, where he delivered meaningful performance improvement. Over eight years at Cardinal Health, he held positions of increasing responsibility in Corporate Development, Business Development, and Strategy.

Prior to joining Cardinal Health, Mr. Schuster served in progressive roles within Investment Banking and M&A at Lehman Brothers, Barclays Capital, and Republic Services. Mr. Schuster began his career as a CPA and Consultant with Ernst & Young.

Suzanne Foster, Chief Executive Officer of AdaptHealth, said, "We are thrilled to welcome Russ to the AdaptHealth team. Russ’s experience leading large-scale growth initiatives fills an important need for the Company. His appointment as Chief Commercial Officer will be critical to the execution of our strategic plan and driving top line growth, while ensuring our commitment to exceptional patient care."

About AdaptHealth Corp.

AdaptHealth is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home, adapt to challenges in their activities of daily living, and thrive. Product and service offerings include (i) sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea, (ii) medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors and insulin pumps), (iii) HME to patients discharged from acute care and other facilities, (iv) oxygen and related chronic therapy services in the home, and (v) other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The Company is proud to partner with an extensive and highly diversified network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. AdaptHealth services beneficiaries of Medicare, Medicaid, and commercial insurance payors, reaching approximately 4.2 million patients annually in all 50 states through its network of approximately 670 locations in 47 states.

AdaptHealth Corp. Jason Clemens, CFA Chief Financial Officer IR@adapthealth.com

Luke Montgomery, CFA SVP, Investor Relations luke.montgomery@adapthealth.com

Grafico Azioni AdaptHealth (NASDAQ:AHCO)
Storico
Da Nov 2024 a Dic 2024 Clicca qui per i Grafici di AdaptHealth
Grafico Azioni AdaptHealth (NASDAQ:AHCO)
Storico
Da Dic 2023 a Dic 2024 Clicca qui per i Grafici di AdaptHealth